Skip to content

MulTi-center prospectIve study determining the sustainability of pain relief and psychosocial and functional responses when utilizing a multiple waveform enabled neurostimulator

MulTi-center prospectIve study determining the sustainability of pain relief and psychosocial and functional responses when utilizing a multiple waveform enabled neurostimulator - Triumph Study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON46110
Enrollment
25
Registered
2017-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronische pijnklachten Chronic Pain

Interventions

Chronic pain
Pain relief
Spinal cord stimulation

Sponsors

St. Jude Medical
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Subject has chronic, intractable pain of the trunk and/or limbs, including unilateral or bilateral pain associated with the following: failed back surgery syndrome and intractable low back and leg pain. 2. Subject has a score of 6 or higher on the NRS for average pain specific to the area(s) of chronic pain being treated over the past 24 hours at the baseline visit. 3. Subject is considered by the Investigator as a candidate for implantation of a spinal cord stimulator system according to the system Instructions For Use. 4. Subject is 18 years of age or older at the time of enrollment. 5. Subject is willing to cooperate with the study requirements including compliance with the regimen and completion of all study visits. 6. Subject has signed and received a copy of the Ethics Committee/Institutional Review Board (EC/IRB) approved informed consent.

Exclusion criteria

Exclusion criteria: 1. Subject currently has a spinal cord stimulation system implanted. 2. Subject has previously failed SCS therapy (either trial system evaluation or permanent implant). 3. Subject has a primary diagnosis of Peripheral Vascular Disease (PVD), Angina Pectoris, or Chronic Migraine. 4. Subject has or plans to have a Peripheral Nerve Stimulation system (PNS), Peripheral Nerve field Stimulation system (PNfS), Dorsal Root Ganglion system (DRG), or implantable infusion pump. 5. Subject is currently participating in another clinical investigation with an active treatment arm. 6. Subject unable to read and/or write.

Design outcomes

Primary

MeasureTime frame
The primary objective is to evaluate sustainable pain relief with a multiple waveform enabled neurostimulator.

Secondary

MeasureTime frame
The secondary objectives are to evaluate the psychosocial and functional responses to burst and tonic stimulation.

Countries

Denmark, Finland, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom, United States of America

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)